UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics

Journal of the American Academy of Dermatology, 2013-11, Vol.69 (5), p.729-735

2013

Volltextzugriff (PDF)

Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics

Journal of the American Academy of Dermatology, 2014-10, Vol.71 (4), p.649-655

2014

Volltextzugriff (PDF)

Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs

Journal of rheumatology, 2022-05, Vol.49 (5), p.454-464

2022

Volltextzugriff (PDF)

CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides

Journal of rheumatology, 2016-01, Vol.43 (1), p.97-120

2016

Volltextzugriff (PDF)

Biosimilars: A Multidisciplinary Perspective

Clinical therapeutics, 2016-05, Vol.38 (5), p.1238-1249

2016

Volltextzugriff (PDF)

Experience with subcutaneous abatacept for rheumatoid arthritis: an update for clinicians

Therapeutic Advances in Musculoskeletal Disease, 2014-10, Vol.6 (5), p.159-168

Khraishi, Majed M.

2014

Volltextzugriff (PDF)

Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry

BMJ open, 2020-08, Vol.10 (8), p.e036245-e036245

2020

Volltextzugriff (PDF)

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study

Therapeutic advances in musculoskeletal disease, 2019-01, Vol.11, p.1759720X19831151-1759720X19831151

2019

Volltextzugriff (PDF)

Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice

Journal of rheumatology, 2017-04, Vol.44 (4), p.519-534

2017

Volltextzugriff (PDF)

Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis

Pediatric rheumatology online journal, 2019-09, Vol.17 (1), p.64-64, Article 64

2019

Volltextzugriff (PDF)

Effectiveness and Safety of Infliximab in Rheumatoid Arthritis: Analysis From a Canadian Multicenter Prospective Observational Registry

Arthritis care & research (2010), 2014-08, Vol.66 (8), p.1142-1151

2014

Volltextzugriff (PDF)

Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study

Rheumatology and therapy., 2018-12, Vol.5 (2), p.551-565

2018

Volltextzugriff (PDF)

Safety profile of abatacept in rheumatoid arthritis: A review

Clinical therapeutics, 2010-10, Vol.32 (11), p.1855-1870

2010

Volltextzugriff (PDF)

Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis

BMJ open, 2016-04, Vol.6 (4), p.e009661-e009661

2016

Volltextzugriff (PDF)

Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages

Journal of rheumatology, 2003-12, Vol.30 (12), p.2529

2003

Volltextzugriff (PDF)

CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitides – Executive Summary

Canadian Journal of Kidney Health and Disease, 2015, Vol.2, p.43-43

2015

Volltextzugriff (PDF)

Comparative overview of safety of the biologics in rheumatoid arthritis

Journal of rheumatology. Supplement, 2009-06, Vol.82, p.25-32

Khraishi, Majed

2009

Volltextzugriff (PDF)

Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network

Journal of rheumatology, 2023-05, Vol.50 (5), p.634-640

2023

Volltextzugriff (PDF)

Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network

Journal of rheumatology, 2023-05, Vol.50 (5), p.641-648

2023

Volltextzugriff (PDF)

Longterm safety and efficacy of tocilizumab in patients with rheumatoid arthritis: a cumulative analysis of up to 4.6 years of exposure

Journal of rheumatology, 2013-06, Vol.40 (6), p.768-780

2013

Volltextzugriff (PDF)

Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs

Journal of rheumatology, 2012-08, Vol.39 (8), p.1559-1582

2012

Volltextzugriff (PDF)

The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (6), p.1003-1008

2016

Volltextzugriff (PDF)

Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Journal of rheumatology, 2023-03, Vol.50 (3), p.426

2023

Volltextzugriff (PDF)

Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs

Journal of rheumatology, 2022-10, Vol.49 (10), p.1092-1099

2022

Volltextzugriff (PDF)

Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)

Annals of the rheumatic diseases, 2018-05, Vol.77 (5), p.690-698

2018

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(64)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(54)
Science & Technology
(54)
Humans
(45)
Rheumatology
(45)
Female
(27)
Male
(26)
Adult
(25)
Middle Aged
(22)
Rheumatoid Arthritis
(22)
Antirheumatic Agents - Therapeutic Use
(18)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Canada
(16)
Diseases Of The Osteoarticular System
(16)
Arthritis, Rheumatoid - Drug Therapy
(15)
Inflammatory Joint Diseases
(15)
Psoriatic Arthritis
(15)
Treatment Outcome
(15)
Psoriasis
(13)
Aged
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics

Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics

Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs

CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides

Biosimilars: A Multidisciplinary Perspective

Experience with subcutaneous abatacept for rheumatoid arthritis: an update for clinicians

Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study

Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice

Reduction in the utilization of prednisone or methotrexate in Canadian claims data following initiation of etanercept in pediatric patients with juvenile idiopathic arthritis

Effectiveness and Safety of Infliximab in Rheumatoid Arthritis: Analysis From a Canadian Multicenter Prospective Observational Registry

Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional Study

Safety profile of abatacept in rheumatoid arthritis: A review

Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis

Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase and protein kinase C-eta in peripheral blood monocyte-derived macrophages

CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitides – Executive Summary

Comparative overview of safety of the biologics in rheumatoid arthritis

Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network

Real-World Retention and Clinical Effectiveness of Secukinumab for Psoriatic Arthritis: Results From the Canadian Spondyloarthritis Research Network

Longterm safety and efficacy of tocilizumab in patients with rheumatoid arthritis: a cumulative analysis of up to 4.6 years of exposure

Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs

The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis

Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs

Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)

Suchergebnisse filtern